Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fatal lorcainide poisoning

J Evers1, U Büttner-Belz

  • 1Medizinische Klinik, Kliniken Köln-Merheim, Germany.

Journal of Toxicology. Clinical Toxicology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

A 15-year-old girl experienced fatal lorcainide poisoning after ingesting 2500 mg of this antiarrhythmic agent. Her rapid decline into bradycardia, shock, coma, and seizures, despite resuscitation, highlights the severe toxicity of lorcainide.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deintensification of Radiotherapy Use in Treatment of Ductal Carcinoma In Situ in the Netherlands-A Nationwide Overview From 2008 Until 2022.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Radiotherapy Trends and Variations in Invasive Non-metastatic Breast Cancer Treatment in the Netherlands: A Nationwide Overview From 2008 to 2019.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Trends and Variation in the Use of Radiotherapy in Non-metastatic Rectal Cancer: a 14-year Nationwide Overview from the Netherlands.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Nonlinear effects at the electrode-tissue interface of deep brain stimulation electrodes.

Journal of neural engineering·2024
Same author

Stimulation-induced changes at the electrode-tissue interface and their influence on deep brain stimulation.

Journal of neural engineering·2022
Same author

[Outcome after surgical treatment of calcaneal fractures].

Der Unfallchirurg·2018
Same journal

Ingestion of high-dose buprenorphine by a 4 year-old child.

Journal of toxicology. Clinical toxicology·2005
Same journal

A reassessment of topical organic phosphorus insecticide exposures and permanent paralysis.

Journal of toxicology. Clinical toxicology·2005
Same journal

Methamphetamine toxicity secondary to intravaginal body stuffing.

Journal of toxicology. Clinical toxicology·2005
Same journal

Duodenal perforation after ibuprofen overdose.

Journal of toxicology. Clinical toxicology·2005
Same journal

Delayed dystonia following pimozide overdose in a child.

Journal of toxicology. Clinical toxicology·2005
Same journal

Pattern of acute poisonings in Mashhad, Iran 1993-2000.

Journal of toxicology. Clinical toxicology·2005
See all related articles

Area of Science:

  • Cardiology
  • Clinical Toxicology
  • Pharmacology

Background:

  • Lorcainide is a Class Ic antiarrhythmic agent.
  • Antiarrhythmic drug toxicity can lead to severe cardiovascular events.
  • Understanding overdose effects is crucial for emergency treatment.

Observation:

  • A 15-year-old female ingested a significant overdose of lorcainide (2500 mg).
  • The patient rapidly developed severe symptoms including bradycardia, shock, coma, and seizures.
  • Despite aggressive resuscitative measures, including catecholamines and sodium bicarbonate, the outcome was fatal.

Findings:

  • Lorcainide overdose can cause life-threatening cardiotoxicity and central nervous system effects.
  • The clinical presentation of lorcainide poisoning resembles that of other Class Ic antiarrhythmic agents.

Related Experiment Videos

  • Rapid and aggressive medical intervention may not prevent fatal outcomes in severe cases.
  • Implications:

    • This case underscores the critical importance of prompt diagnosis and management of antiarrhythmic drug toxicity.
    • It highlights the potential for severe adverse events even with therapeutic agents.
    • Further research into managing severe lorcainide poisoning may be warranted.